Detalhe da pesquisa
1.
Progress report of a cross-organ and biomarker-based basket-type clinical trial: BELIEVE Trial.
Cancer Sci
; 115(2): 555-563, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38041215
2.
Platform trial for off-label oncology drugs using comprehensive genomic profiling under the universal public healthcare system: the BELIEVE trial.
Int J Clin Oncol
; 29(2): 89-95, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38112833
3.
[Clinical analysis of chronic myeloid leukemia patients complicated with chronic kidney impairment during treatment with tyrosine kinase inhibitors].
Rinsho Ketsueki
; 57(3): 340-5, 2016 Mar.
Artigo
Japonês
| MEDLINE | ID: mdl-27076247
4.
[Autoimmune hemolytic anemia with normal serum lactate dehydrogenase level].
Rinsho Ketsueki
; 56(11): 2341-5, 2015 Nov.
Artigo
Japonês
| MEDLINE | ID: mdl-26666722
5.
Pregnancy and delivery in a PNH patient treated with eculizumab.
Rinsho Ketsueki
; 55(11): 2288-93, 2014 11.
Artigo
Japonês
| MEDLINE | ID: mdl-25501409
6.
Dabrafenib and trametinib administration in patients with BRAF V600E/R or non-V600 BRAF mutated advanced solid tumours (BELIEVE, NCCH1901): a multicentre, open-label, and single-arm phase II trial.
EClinicalMedicine
; 69: 102447, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38333370
7.
Exceptional response to alectinib for duodenal carcinoma with ALK fusion: A case report and literature review.
Front Oncol
; 12: 1064944, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36713517
8.
Genomic medicine in clinical practice: national genomic medicine program in Japan.
Cancer Biol Med
; 21(1)2023 10 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37818596
9.
CD3+ CD56+ EBER1+ atypical extraosseous plasmacytoma of the nasal cavity.
Int J Hematol
; 108(3): 344-347, 2018 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-29572766